SilverBacteriV1, Main, Corpus, bibRecord, 000135

Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a Pulicaria vulgaris Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.

Identifieur interne : 000135 ( Main/Corpus ); précédent : 000134; suivant : 000136

Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a Pulicaria vulgaris Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.

Auteurs : Majid Sharifi-Rad ; Pawel Pohl

Source :

Nanomaterials (Basel, Switzerland) [ 2079-4991 ] ; 2020.

RBID : pubmed:32235379

Abstract

In this study, very simple and fast one-step synthesis of biogenic silver chloride nanoparticles (AgCl-NPs) using a Pulicaria vulgaris Gaertn. aerial part extract from an aqueous solution of silver nitrate at room temperature is proposed. The proceedings of the reaction were investigated by UV-Vis spectroscopy. AgCl-NPs were characterized using X-ray diffraction spectroscopy (XRD), Fourier-transform infrared spectroscopy (FTIR), and transmission electron microscopy (TEM). Antibacterial and antifungal activities of these nanoparticles were evaluated by disk diffusion and microdilution methods against Staphylococcus aureus, Escherichia coli, Candida albicans, and C. glabrata. In addition, the antioxidant activity of the synthesized AgCl-NPs was determined by the DPPH radical scavenging assay. The antimicrobial test confirmed the bactericidal activity of biosynthesized AgCl-NPs against Gram-positive and Gram-negative bacteria. They also exhibited good antifungal activities with minimum inhibitory concentration (MIC) values ranging from 40 to 60 µg/mL against Candida glabrata and Candida albicans, respectively. In addition, biosynthesized AgCl-NPs were established to have remarkable antioxidant activity. All this pointed out that the proposed new biosynthesis approach resulted in production of AgCl-NPs with convenient biomedical applications.

DOI: 10.3390/nano10040638
PubMed: 32235379
PubMed Central: PMC7221712

Links to Exploration step

pubmed:32235379

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a <i>Pulicaria vulgaris</i>
 Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.</title>
<author><name sortKey="Sharifi Rad, Majid" sort="Sharifi Rad, Majid" uniqKey="Sharifi Rad M" first="Majid" last="Sharifi-Rad">Majid Sharifi-Rad</name>
<affiliation><nlm:affiliation>Department of Range and Watershed Management, Faculty of Water and Soil, University of Zabol, Zabol 98613-35856, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pohl, Pawel" sort="Pohl, Pawel" uniqKey="Pohl P" first="Pawel" last="Pohl">Pawel Pohl</name>
<affiliation><nlm:affiliation>Department of Analytical Chemistry and Chemical Metallurgy, Faculty of Chemistry, University of Science and Technology, Wyspianskiego 27, 50370 Wroclaw, Poland.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32235379</idno>
<idno type="pmid">32235379</idno>
<idno type="doi">10.3390/nano10040638</idno>
<idno type="pmc">PMC7221712</idno>
<idno type="wicri:Area/Main/Corpus">000135</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000135</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a <i>Pulicaria vulgaris</i>
 Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.</title>
<author><name sortKey="Sharifi Rad, Majid" sort="Sharifi Rad, Majid" uniqKey="Sharifi Rad M" first="Majid" last="Sharifi-Rad">Majid Sharifi-Rad</name>
<affiliation><nlm:affiliation>Department of Range and Watershed Management, Faculty of Water and Soil, University of Zabol, Zabol 98613-35856, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pohl, Pawel" sort="Pohl, Pawel" uniqKey="Pohl P" first="Pawel" last="Pohl">Pawel Pohl</name>
<affiliation><nlm:affiliation>Department of Analytical Chemistry and Chemical Metallurgy, Faculty of Chemistry, University of Science and Technology, Wyspianskiego 27, 50370 Wroclaw, Poland.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Nanomaterials (Basel, Switzerland)</title>
<idno type="ISSN">2079-4991</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In this study, very simple and fast one-step synthesis of biogenic silver chloride nanoparticles (AgCl-NPs) using a <i>Pulicaria vulgaris</i>
 Gaertn. aerial part extract from an aqueous solution of silver nitrate at room temperature is proposed. The proceedings of the reaction were investigated by UV-Vis spectroscopy. AgCl-NPs were characterized using X-ray diffraction spectroscopy (XRD), Fourier-transform infrared spectroscopy (FTIR), and transmission electron microscopy (TEM). Antibacterial and antifungal activities of these nanoparticles were evaluated by disk diffusion and microdilution methods against <i>Staphylococcus aureus</i>
, <i>Escherichia coli</i>
, <i>Candida albicans,</i>
 and <i>C. glabrata</i>
. In addition, the antioxidant activity of the synthesized AgCl-NPs was determined by the DPPH radical scavenging assay. The antimicrobial test confirmed the bactericidal activity of biosynthesized AgCl-NPs against Gram-positive and Gram-negative bacteria. They also exhibited good antifungal activities with minimum inhibitory concentration (MIC) values ranging from 40 to 60 µg/mL against <i>Candida glabrata</i>
 and <i>Candida albicans</i>
, respectively. In addition, biosynthesized AgCl-NPs were established to have remarkable antioxidant activity. All this pointed out that the proposed new biosynthesis approach resulted in production of AgCl-NPs with convenient biomedical applications.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32235379</PMID>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-4991</ISSN>
<JournalIssue CitedMedium="Print"><Volume>10</Volume>
<Issue>4</Issue>
<PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>Nanomaterials (Basel, Switzerland)</Title>
<ISOAbbreviation>Nanomaterials (Basel)</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a <i>Pulicaria vulgaris</i>
 Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E638</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/nano10040638</ELocationID>
<Abstract><AbstractText>In this study, very simple and fast one-step synthesis of biogenic silver chloride nanoparticles (AgCl-NPs) using a <i>Pulicaria vulgaris</i>
 Gaertn. aerial part extract from an aqueous solution of silver nitrate at room temperature is proposed. The proceedings of the reaction were investigated by UV-Vis spectroscopy. AgCl-NPs were characterized using X-ray diffraction spectroscopy (XRD), Fourier-transform infrared spectroscopy (FTIR), and transmission electron microscopy (TEM). Antibacterial and antifungal activities of these nanoparticles were evaluated by disk diffusion and microdilution methods against <i>Staphylococcus aureus</i>
, <i>Escherichia coli</i>
, <i>Candida albicans,</i>
 and <i>C. glabrata</i>
. In addition, the antioxidant activity of the synthesized AgCl-NPs was determined by the DPPH radical scavenging assay. The antimicrobial test confirmed the bactericidal activity of biosynthesized AgCl-NPs against Gram-positive and Gram-negative bacteria. They also exhibited good antifungal activities with minimum inhibitory concentration (MIC) values ranging from 40 to 60 µg/mL against <i>Candida glabrata</i>
 and <i>Candida albicans</i>
, respectively. In addition, biosynthesized AgCl-NPs were established to have remarkable antioxidant activity. All this pointed out that the proposed new biosynthesis approach resulted in production of AgCl-NPs with convenient biomedical applications.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharifi-Rad</LastName>
<ForeName>Majid</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Range and Watershed Management, Faculty of Water and Soil, University of Zabol, Zabol 98613-35856, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pohl</LastName>
<ForeName>Pawel</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">0000-0003-1844-7188</Identifier>
<AffiliationInfo><Affiliation>Department of Analytical Chemistry and Chemical Metallurgy, Faculty of Chemistry, University of Science and Technology, Wyspianskiego 27, 50370 Wroclaw, Poland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Nanomaterials (Basel)</MedlineTA>
<NlmUniqueID>101610216</NlmUniqueID>
<ISSNLinking>2079-4991</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pulicaria vulgaris</Keyword>
<Keyword MajorTopicYN="N">biomedical application</Keyword>
<Keyword MajorTopicYN="N">green synthesis</Keyword>
<Keyword MajorTopicYN="N">silver chloride nanoparticle</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>03</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32235379</ArticleId>
<ArticleId IdType="pii">nano10040638</ArticleId>
<ArticleId IdType="doi">10.3390/nano10040638</ArticleId>
<ArticleId IdType="pmc">PMC7221712</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Colloids Surf B Biointerfaces. 2013 Aug 1;108:255-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23563291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 2007 Mar;73(6):1712-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17261510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 2005 Nov;71(11):7589-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16269810</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Biol (Noisy-le-grand). 2018 Jun 25;64(8):18-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29981679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nanomedicine. 2018 Nov 27;13:8013-8024</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30568442</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Pharm Bull (Tokyo). 2012;60(3):363-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22382417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Rev. 2004 Sep;104(9):3893-946</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15352782</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>3 Biotech. 2015 Apr;5(2):195-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28324578</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Prod Commun. 2012 Feb;7(2):257-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22474974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Materials (Basel). 2015 Oct 29;8(11):7278-7308</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28793638</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Materials (Basel). 2018 Jun 03;11(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29865278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Molecules. 2019 Nov 30;24(23):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31801244</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Biochem Biotechnol. 2012 Jun;167(4):776-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22592777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Biodivers. 2010 Feb;7(2):327-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20151381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Colloids Surf B Biointerfaces. 2013 Feb 1;102:288-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23006568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biomater Sci. 2017 Jan 31;5(2):247-257</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27921105</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Soc Rev. 2006 Jul;35(7):583-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16791330</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2019 Oct 29;9(1):15520</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31664049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Microbiol. 2019 Jul 1;2019:8642303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31354833</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Ethnopharmacol. 2001 Feb;74(2):173-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11167035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):50-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19896347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):844-851</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30879351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Pharm. 2003 Jun;53(2):73-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14764241</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nanomedicine. 2011;6:1117-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21698080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2019 Aug 12;14(8):e0220950</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31404086</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000135 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000135 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Terre
   |area=    SilverBacteriV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32235379
   |texte=   Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a Pulicaria vulgaris Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32235379" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SilverBacteriV1

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 1 22:59:42 2021. Site generation: Mon Feb 1 23:01:29 2021

	Serveur d'exploration SilverBacteriV1
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SilverBacteriV1

Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a Pulicaria vulgaris Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.

Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a Pulicaria vulgaris Gaertn. Aerial Part Extract and Their Application as Antibacterial, Antifungal and Antioxidant Agents.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki